FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 613 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR FDA Grants Accelerated Approval to Zenocutuzumab-zbco for Non-Small Cell Lung Cancer... January 10, 2025 Bride Learns Sign Language, Surprises Groom’s Deaf Parents & Signs Her... January 11, 2022 FDA Approves Ivosidenib for Myelodysplastic Syndromes November 9, 2023 Cholesterol Drug May Help Protect the Heart during Chemotherapy for Lymphoma September 8, 2023 Load more HOT NEWS COVID-19, Vaccines, and the Immune System: Emerging Research from NCI’s SeroNet FDA Approves Abatacept for Prophylaxis of Acute Graft Versus Host Disease EMA Recommends Extension of Therapeutic Indications for Cabozantinib and Nivolumab Surveillance and Early Cancer Detection are Associated with Improved Survival in...
